Furthermore, a clinical study showed that SCFAs could alleviate the development of AF through G protein-coupled receptor 43/NOD-like receptor family pyrin domain containing 3 (GPR43/NLRP3) signal pathways (Zuo et al., 2022). The gene discussed is FFAR2; the disease is atrial fibrillation.